From L-R: Zavain Dar, Adam Goulburn and Nan Li (Dimension)
‘Siloing is just so outdated’: New $350M VC fund aims to digitize life sciences
As technology increasingly helps find drug targets, enhance the diagnosis of diseases, speed up the testing of new therapeutics and essentially angle its way into …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
